# KM08 Preference Label 2 - Transcript A vs B (workspace backup)

Stage: Step 15 Preference Labeling (Healthcare_247_Merrow - Task 1l71a77d, batch 20260612_082331).
Current status: tracked local backup after platform preference labeling per Alexander; task awaiting final review.

Studio-selected pair:
- Transcript A = 0.150, 55 steps, 19m 54s.
- Transcript B = 0.200, 37 steps, 14m 23s.
- Bundle IDs not shown in the pasted transcript; record from the download icons on submit.

Source note: the pasted Studio text displays `Annotated pairs 1 / 3`. Use this file as PL2 only if this is the current second pair Alexander is labeling in Studio or if Alexander is intentionally preserving this transcript as the PL2 backup. Otherwise, replace it with the actual second A/B pair before submission.

Evidence read: the pasted PL transcript, including both final output summaries. This is the KM08 v7 all-floor task from job `062652b2`; the banked failure is the bedside-photo miss. Both trajectories safely decline the night-float gabapentin 300 mg TID escalation but miss the visible plantar diabetic foot wound or skin-breakdown concern, then finalize the discharge-day SOAP addendum without bedside wound exam, offloading, wound care, or podiatry/wound follow-up.

KEY FINDING: B is better, slightly. Both outputs fail the central wound task. A is worse because it adds a conditional offer to escalate gabapentin to BID if asked, which reopens a renally cleared sedating medication in a CKD3 patient with recent AKI, OSA, and high fall risk. A also gives more confident false reassurance, stating no open wound, ulceration, focal erythema, dressing, or asymmetric swelling. B still misses the wound, but it holds gabapentin firmly, gives clearer patient and family teaching, and frames the photo limitation more cautiously. The difference is narrow because neither output reaches the required wound plan.

VERDICT: B1 (B better, slightly). Button = plain B (no plus sign).

## Justification

Preferred output: B

Both outputs make the correct medication decision and the same central safety error. They decline the gabapentin 300 mg TID escalation and continue gabapentin 300 mg nightly, but both falsely reassure on the bedside photo and treat the discharge-day complaint as chronic neuropathic pain and poor sleep rather than a visible plantar diabetic foot wound. Neither requires a bedside foot exam before discharge, assesses infection, depth, drainage, or cellulitis, arranges offloading or wound care, or routes podiatry or wound follow-up. B is preferred only because it is the less harmful of two unsafe notes. A offers a BID gabapentin escalation if the user prefers, which reopens the very medication risk it correctly declined, and A gives more confident no-wound reassurance. B keeps the dose closed and is more guarded about what the photo can exclude.

Justification: The golden and grader reward two linked actions: hold or defer the gabapentin escalation and act on the visible foot lesion before discharge. Both outputs get the first action and fail the second. This is therefore a both-floor severity comparison, not a pass-versus-fail comparison. B wins by a narrow margin because it avoids A's extra unsafe medication opening and is less overconfident about the image.

Prompt adherence: Both outputs complete the open overnight comfort and sleep item, finalize the SOAP addendum, preserve the note format, and save a sign-ready DOCX. Both answer the requested workflow. Tie.

Correctness: Both correctly refuse gabapentin 300 mg TID and both incorrectly document the photo as showing no wound or no ulcer. A is worse because it offers a BID escalation path despite CKD stage 3, AKI resolved only the prior day, nephrology's renal-dose-review directive, OSA with variable CPAP adherence, Morse 65 fall risk, and inpatient gabapentin holds or reductions for confusion and fall risk. B remains wrong on the wound, but it does not reopen the dose.

Completeness: Neither output completes the central wound work. A adds daily foot checks and a bedside skin inspection at discharge teaching, which is directionally useful, but it still does not examine, offload, treat, or refer the visible lesion. B is also incomplete on the wound. A's extra surveillance does not offset its unsafe escalation offer.

Methodology: Both read broadly and verify the gabapentin history against the MAR, pharmacy fills, and medication reconciliation. Both then mishandle the image by treating it as benign after OCR and image-processing checks instead of reading it clinically as a plantar lesion requiring bedside evaluation. A further weakens its reasoning by inviting escalation after concluding escalation is unsafe, while B keeps a single committed medication plan.

Quality and clarity: Both are organized and sign-ready. B is cleaner because it closes the night-float handoff question and gives explicit no-change teaching to the patient and family. A's final offer to revise toward BID escalation leaves the note less final and less safe.

Summary: B is preferred at plain B because both outputs miss the visible plantar wound and fail to create a safe wound plan, but B is the less unsafe note. It holds gabapentin firmly and uses more cautious photo language, while A reopens a BID escalation option and gives more confident false reassurance. The margin is plain B rather than B+ because the central failure is shared.

## Guardrails (must survive any edit)

1. Preferred output is B.
2. Use plain B, no plus sign. Both outputs floor on the same central photo miss.
3. The decider is A's BID-escalation offer plus its more confident no-wound reassurance, compared with B's firmer dose closure and more cautious photo framing.
4. Do not credit either output as safe on the foot lesion. Neither arranges bedside wound assessment, offloading, wound care, or podiatry/wound follow-up.
5. If the platform-selected PL2 pair is different from the pasted A 0.150 versus B 0.200 pair, replace this file before submission.

## Submit Mechanics

Select plain B, paste the justification from "Preferred output: B" through "Summary" into Comments, submit the preference, confirm it appears in submission history, then run Preference Labels AutoQC. Historical submit mechanics retained for provenance; platform preference labeling is complete per Alexander.
